baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out LLY/ DE000GQ2NYQ8 /

01/08/2024 10:08:00	Chg.+0.69	Bid11:08:49	Ask11:08:49	Underlying	Strike price	Expiration date	Option type
24.90EUR	+2.85%	24.69 Bid Size: 2,000	24.76 Ask Size: 2,000	Eli Lilly and Co	539.4203 USD	31/12/2078	Call

TeleTrader 08/07 Eli Lilly launches $3.2B tender offer for Morphic

TeleTrader 02/07 US FDA approves Eli Lilly's Alzheimer's drug

GlobeNewswire 01/07 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...

GlobeNewswire 28/06 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...

TeleTrader 25/06 Lilly partners with OpenAI to combat drug-resistance bacteria

GlobeNewswire 21/06 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda

GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

GlobeNewswire 17/06 Atossa Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire 14/06 TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug

GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...

GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...

TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO

GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine

GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024

GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District

TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost

TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China

GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 13/05 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 13/05 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results

Goldman Sachs Knock-Out LLY/ DE000GQ2NYQ8 /

If you wish to receive reply to your feedback, please provide your email address.